C33H41N5O3 — CID 10120239
N-[(1S,2R)-2-[[(3S)-5-methyl-2-oxo-1-(1,3,4,5-tetrahydro-2-benzazepin-2-yl)hexan-3-yl]carbamoyl]cyclohexyl]quinoxaline-2-carboxamide (PubChem CID 10120239) has the molecular formula C33H41N5O3 and a molecular weight of 555.72 g/mol. Its IUPAC name is N-[(1S,2R)-2-[[(3S)-5-methyl-2-oxo-1-(1,3,4,5-tetrahydro-2-benzazepin-2-yl)hexan-3-yl]carbamoyl]cyclohexyl]quinoxaline-2-carboxamide.
| Compound Name | N-[(1S,2R)-2-[[(3S)-5-methyl-2-oxo-1-(1,3,4,5-tetrahydro-2-benzazepin-2-yl)hexan-3-yl]carbamoyl]cyclohexyl]quinoxaline-2-carboxamide |
|---|---|
| PubChem CID | 10120239 |
| Molecular Formula | C33H41N5O3 |
| Molecular Weight | 555.72 g/mol |
| Exact Mass | 555.32 |
| IUPAC Name | N-[(1S,2R)-2-[[(3S)-5-methyl-2-oxo-1-(1,3,4,5-tetrahydro-2-benzazepin-2-yl)hexan-3-yl]carbamoyl]cyclohexyl]quinoxaline-2-carboxamide |
| SMILES | CC(C)C[C@H](NC(=O)[C@@H]1CCCC[C@@H]1NC(=O)c1cnc2ccccc2n1)C(=O)CN1CCCc2ccccc2C1 |
| InChI | InChI=1S/C33H41N5O3/c1-22(2)18-29(31(39)21-38-17-9-12-23-10-3-4-11-24(23)20-38)37-32(40)25-13-5-6-14-26(25)36-33(41)30-19-34-27-15-7-8-16-28(27)35-30/h3-4,7-8,10-11,15-16,19,22,25-26,29H,5-6,9,12-14,17-18,20-21H2,1-2H3,(H,36,41)(H,37,40)/t25-,26+,29+/m1/s1 |
| InChIKey | DLADRCPTGMCGBB-ALTZYDRJSA-N |
| XLogP | 4.47 |
| TPSA | 104.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 41 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 555.72 |
| LogP ≤ 5 | 4.47 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |